Contained Mycobacterium tuberculosis infection induces concomitant and heterologous protection

Abstract excerpt

Progress in tuberculosis vaccine development is hampered by an incomplete understanding of the immune mechanisms that protect against infection with Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis. Although the M72/ASOE1 trial yielded encouraging results (54% efficacy in subjects with prior exposure to Mtb), a highly effective vaccine against adult tuberculosis remains elusive. We show that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immune responses and vaccinations
• Share to Mycobacterium research and diagnosis
• Share to Tuberculosis Research and Epidemiology